C1 inhibitor testing is essential for diagnosing and managing hereditary angioedema (HAE) and other complement-related disorders. This test measures the levels and functionality of the C1 inhibitor protein, which regulates the complement and contact systems. Deficiencies or dysfunctions in C1 inhibitor can lead to uncontrolled inflammation and swelling. Accurate C1 inhibitor testing enables early diagnosis, effective treatment planning, and monitoring of therapeutic interventions, improving patient outcomes in complement-mediated conditions.
Last update on April 2, 5:33 am by cailynnjohnson.
Be the first person to like this.
